Quest Diagnostics Inc (DGX)

DGX (NYSE:Health Services) EQUITY
$98.22
neg -0.62
-0.63%
Today's Range: 98.12 - 98.65 | DGX Avg Daily Volume: 874,700
Last Update: 03/29/17 - 4:02 PM EDT
Volume: 500,402
YTD Performance: 7.55%
Open: $98.53
Previous Close: $98.84
52 Week Range: $69.88 - $100.00
Oustanding Shares: 137,495,276
Market Cap: 13,562,534,025
6-Month Chart
TheStreet Ratings Grade for DGX
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 3 3 3 1
Moderate Buy 0 0 0 0
Hold 13 12 12 13
Moderate Sell 0 1 1 1
Strong Sell 1 1 1 1
Mean Rec. 2.72 2.78 2.78 3.02
Latest Dividend: 0.45
Latest Dividend Yield: 1.82%
Dividend Ex-Date: 04/03/17
Price Earnings Ratio: 21.87
Price Earnings Comparisons:
DGX Sector Avg. S&P 500
21.87 21.90 30.30
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
7.72% 40.40% 71.00%
GROWTH 12 Mo 3 Yr CAGR
Revenue 0.30 0.10 0.02
Net Income -4.70 -0.20 -0.06
EPS -7.40 -0.20 -0.06
Earnings for DGX:
EBITDA 1.40B
Revenue 7.52B
Average Earnings Estimates
Qtr (03/17) Qtr (06/17) FY (12/17) FY (12/18)
Average Estimate $1.18 $1.43 $5.44 $5.75
Number of Analysts 13 12 14 14
High Estimate $1.26 $1.44 $5.47 $5.90
Low Estimate $1.14 $1.39 $5.39 $5.60
Prior Year $1.12 $1.34 $5.15 $5.44
Growth Rate (Year over Year) 5.29% 6.34% 5.69% 5.59%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
Bullish
Dec 12, 2016 | 7:37 AM EST
DGX was upgraded to Buy, Goldman Sachs said. $102 price target. Company can gain market share and realize operating leverage.
Here's a window into what institutional investors may be doing and how to profit from that.
Let me give you the unassailable themes.
LH's $5.7B Covance takeover could be just what the doctor ordered.
Charts show DGX should break out above resistance soon.
Questions will continue to swirl until facts emerge.
Bullish
Oct 16, 2015 | 7:07 AM EDT
DGX was upgraded from Underperform to Market Perform, Wells Fargo said. Valuation call.  
Quest could be vulnerable to a deep correction, but a decline to next support around $60 seems like the path of least resistance. 
Selling covered calls and naked puts can reduce risk. (Updated)

Columnist Conversations

View Chart »  View in New Window » To fail or not to fail is the question.  The video I d...
I've been suspect of CSCO since early this month and am still convinced a pullback is on the way. The stock h...
I forgot to list my short positions in RH puts in my disclosure on retail shares. Paul
Retails shares, almost without exception, are surging higher from very previously, very depressed levels. T...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.